NMA participating in publications of real world data

16 mars, 2023 Peter Carlqvist

One of the key challenges in the health economic modeling of metastatic cancer is the validation of survival extrapolation, #NMA is looking into ways to give substance to the strategies it pursues. We have recently collaborated with our clients on two papers on the topic. One is specific to breast cancer, while the other discusses a range of metastatic cancers. Both use the Swedish national health registries. Links below:

Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study

Overall survival of individuals with metastatic cancer in Sweden: a nationwide study